COVID-19: What Do Rheumatologists Need to Know?

被引:0
作者
Gillian E. Fitzgerald
Sinead Maguire
Nigil Haroon
机构
[1] Toronto Western Hospital,Department of Rheumatology
[2] St James’ Hospital,Department of Rheumatology
[3] University of Toronto,Medicine and Rheumatology
[4] University Health Network and Mount Sinai Hospital,undefined
[5] Scientist,undefined
[6] Krembil Research Institute,undefined
来源
Current Rheumatology Reports | 2021年 / 23卷
关键词
COVID-19; Prevalence; Outcomes; Clinical trials; Tele-medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 163 条
  • [1] Meroni PL(2018)Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs Clin Exp Rheumatol 36 317-328
  • [2] Zavaglia D(1998)Infection in systemic lupus Erythematosus Rheum Dis Clin N Am 24 423-456
  • [3] Girmenia C(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet. 395 1054-1062
  • [4] Petri M(2020)Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study J Am Geriatr Soc 68 E19-e23
  • [5] Zhou F(2020)Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study BMJ 368 m1091-506
  • [6] Yu T(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 497-ee64
  • [7] Du R(2020)COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study Lancet Rheumatol 2 e557-668
  • [8] Fan G(2020)Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Ann Rheum Dis 79 667-2796
  • [9] Liu Y(2020)Determinants of COVID-19 disease severity in patients with underlying rheumatic disease Clin Rheumatol 39 2789-ee56
  • [10] Liu Z(2020)COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study Lancet Rheumatol 2 e549-842